Short Interest in Exponent, Inc. (NASDAQ:EXPO) Rises By 5.8%

Exponent, Inc. (NASDAQ:EXPOGet Free Report) was the recipient of a significant growth in short interest during the month of June. As of June 15th, there was short interest totalling 1,450,000 shares, a growth of 5.8% from the May 31st total of 1,370,000 shares. Approximately 2.9% of the company’s stock are short sold. Based on an average daily trading volume, of 235,900 shares, the short-interest ratio is currently 6.1 days.

Analyst Upgrades and Downgrades

Separately, Truist Financial upped their price objective on shares of Exponent from $95.00 to $100.00 and gave the stock a “buy” rating in a report on Monday, April 29th.

Check Out Our Latest Stock Report on EXPO

Insider Buying and Selling

In other Exponent news, VP Bradley A. James sold 3,528 shares of the business’s stock in a transaction that occurred on Monday, May 6th. The shares were sold at an average price of $95.00, for a total value of $335,160.00. Following the completion of the sale, the vice president now directly owns 2,030 shares of the company’s stock, valued at $192,850. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, VP Bradley A. James sold 3,528 shares of the company’s stock in a transaction dated Monday, May 6th. The stock was sold at an average price of $95.00, for a total transaction of $335,160.00. Following the completion of the sale, the vice president now owns 2,030 shares in the company, valued at approximately $192,850. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Paul R. Johnston sold 7,000 shares of the firm’s stock in a transaction that occurred on Wednesday, June 12th. The shares were sold at an average price of $95.83, for a total value of $670,810.00. Following the completion of the transaction, the director now directly owns 80,742 shares in the company, valued at $7,737,505.86. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 50,067 shares of company stock worth $4,734,995. Insiders own 2.10% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the stock. GAMMA Investing LLC grew its position in Exponent by 67.7% during the second quarter. GAMMA Investing LLC now owns 379 shares of the business services provider’s stock worth $36,000 after buying an additional 153 shares in the last quarter. Benjamin F. Edwards & Company Inc. raised its stake in shares of Exponent by 866.0% in the first quarter. Benjamin F. Edwards & Company Inc. now owns 512 shares of the business services provider’s stock valued at $42,000 after purchasing an additional 459 shares in the last quarter. Janiczek Wealth Management LLC lifted its position in Exponent by 293.7% in the first quarter. Janiczek Wealth Management LLC now owns 626 shares of the business services provider’s stock worth $52,000 after purchasing an additional 467 shares during the period. Principal Securities Inc. acquired a new stake in Exponent during the fourth quarter worth $69,000. Finally, YHB Investment Advisors Inc. bought a new stake in Exponent in the 1st quarter valued at $75,000. Institutional investors own 92.37% of the company’s stock.

Exponent Stock Performance

Exponent stock opened at $94.44 on Thursday. Exponent has a 52 week low of $64.61 and a 52 week high of $102.72. The firm has a market capitalization of $4.79 billion, a PE ratio of 47.70 and a beta of 0.65. The business’s 50-day simple moving average is $94.50 and its 200-day simple moving average is $86.85.

Exponent (NASDAQ:EXPOGet Free Report) last released its earnings results on Thursday, April 25th. The business services provider reported $0.59 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.46 by $0.13. Exponent had a return on equity of 28.13% and a net margin of 18.72%. The firm had revenue of $137.21 million for the quarter, compared to analyst estimates of $125.98 million. During the same quarter last year, the firm posted $0.56 EPS. The company’s revenue was up 6.6% on a year-over-year basis. Research analysts forecast that Exponent will post 1.92 earnings per share for the current year.

Exponent Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, June 21st. Shareholders of record on Friday, June 7th were issued a $0.28 dividend. This represents a $1.12 dividend on an annualized basis and a yield of 1.19%. The ex-dividend date was Friday, June 7th. Exponent’s dividend payout ratio (DPR) is presently 56.57%.

Exponent Company Profile

(Get Free Report)

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.

Further Reading

Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.